Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Hypertension risk with programmed death ligand 1 (PD-L1) antibodies.
| Molecular target | Incidence of hypertension | Relative risk of hypertension | Reference | |
|---|---|---|---|---|
| Atezolizumab | PD-L1 | 0%-19% | – | (9, 33–35) |
PD-L1, programmed death ligand 1; -, not available.
*durvalumab plus ramucirumab, durvalumab plus olaparib/cediranib, and velumab plus axitinib associated with hypertension.
